Compare AJANTA PHARMA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALKEM LABORATORIES AJANTA PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 28.5 23.4 121.6% View Chart
P/BV x 7.9 5.6 140.1% View Chart
Dividend Yield % 0.4 0.9 51.9%  

Financials

 AJANTA PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ALKEM LABORATORIES
Mar-20
AJANTA PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,4222,720 52.3%   
Low Rs8981,660 54.1%   
Sales per share (Unadj.) Rs233.5697.9 33.5%  
Earnings per share (Unadj.) Rs44.096.1 45.7%  
Cash flow per share (Unadj.) Rs52.2117.3 44.5%  
Dividends per share (Unadj.) Rs9.0025.00 36.0%  
Dividend yield (eoy) %0.81.1 68.0%  
Book value per share (Unadj.) Rs255.1515.2 49.5%  
Shares outstanding (eoy) m88.02119.57 73.6%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.03.1 158.3%   
Avg P/E ratio x26.422.8 115.8%  
P/CF ratio (eoy) x22.218.7 119.1%  
Price / Book Value ratio x4.54.3 107.0%  
Dividend payout %20.526.0 78.7%   
Avg Mkt Cap Rs m102,081261,879 39.0%   
No. of employees `0006.814.3 47.4%   
Total wages/salary Rs m4,30715,055 28.6%   
Avg. sales/employee Rs Th3,022.65,822.6 51.9%   
Avg. wages/employee Rs Th633.41,050.5 60.3%   
Avg. net profit/employee Rs Th569.1802.0 71.0%   
INCOME DATA
Net Sales Rs m20,55483,444 24.6%  
Other income Rs m2111,042 20.2%   
Total revenues Rs m20,76584,486 24.6%   
Gross profit Rs m5,66414,734 38.4%  
Depreciation Rs m7212,528 28.5%   
Interest Rs m12651 1.8%   
Profit before tax Rs m5,14312,598 40.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2731,105 115.2%   
Profit after tax Rs m3,87011,493 33.7%  
Gross profit margin %27.617.7 156.1%  
Effective tax rate %24.88.8 282.3%   
Net profit margin %18.813.8 136.7%  
BALANCE SHEET DATA
Current assets Rs m11,81254,960 21.5%   
Current liabilities Rs m3,77632,433 11.6%   
Net working cap to sales %39.127.0 144.8%  
Current ratio x3.11.7 184.6%  
Inventory Days Days7780 97.3%  
Debtors Days Days8272 113.1%  
Net fixed assets Rs m14,39832,710 44.0%   
Share capital Rs m175239 73.4%   
"Free" reserves Rs m22,27761,368 36.3%   
Net worth Rs m22,45261,607 36.4%   
Long term debt Rs m71,592 0.4%   
Total assets Rs m26,96299,433 27.1%  
Interest coverage x444.320.4 2,182.0%   
Debt to equity ratio x00 1.1%  
Sales to assets ratio x0.80.8 90.8%   
Return on assets %14.412.2 117.9%  
Return on equity %17.218.7 92.4%  
Return on capital %23.021.0 109.5%  
Exports to sales %019.1 0.0%   
Imports to sales %03.0 0.0%   
Exports (fob) Rs mNA15,917 0.0%   
Imports (cif) Rs mNA2,483 0.0%   
Fx inflow Rs m10,68216,061 66.5%   
Fx outflow Rs m2,1022,483 84.7%   
Net fx Rs m8,58013,578 63.2%   
CASH FLOW
From Operations Rs m3,7485,851 64.1%  
From Investments Rs m-2,228-7,414 30.1%  
From Financial Activity Rs m-1,475792 -186.3%  
Net Cashflow Rs m45-731 -6.2%  

Share Holding

Indian Promoters % 73.8 66.9 110.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 33.1 4.7%  
FIIs % 7.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 0.0 -  
Shareholders   20,968 68,381 30.7%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  J.B.CHEMICALS  NEULAND LABS  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


May 7, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS